Vascular Health Sciences Announces Promising Results of Healthcare Conference Attendees' Artery Health When Taking Arterosil HP - FOX 8 WVUE New Orleans News, Weather, Sports

Vascular Health Sciences Announces Promising Results of Healthcare Conference Attendees' Artery Health When Taking Arterosil HP

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: Vascular Health Sciences

During the recent Age Management Medicine Group Conference in Las Vegas, conference attendees measured their artery health before and after taking Arterosil HP with impressive results.

LAS VEGAS (PRWEB) January 07, 2013

After the recent Age Management Medicine Group Conference in Las Vegas, Vascular Health Sciences reported promising initial results and high interest in Arterosil HP among health practitioners attending the conference. Now, the company announces the more detailed results calculated after the conference, which show fascinating findings.

The results indicate that of the volunteers who visited Arterosil HP booth during the conference to have their glycocalyx measured using new GlycoCheck technology who had full data sets, most had better artery health scores after taking samples of Arterosil HP than before.

“The bottom line is that Arterosil HP clearly helps support the glycocalyx,” said Vascular Health Sciences Co-Founder and CEO Bob Long. “GlycoCheck provides a unique and novel technology to assess artery health in real time. The more trials we conduct, both in the clinical setting and in a non-controlled conference setting, the more positive evidence we observe that proves Arterosil HP works.”

Called the PBR score, the GlycoCheck measurement refers to the Perfused Boundary Region. Blood cells detected closely contained in the center of the blood vessel indicate the glycocalyx is dense and full, and more able to protect the blood vessel wall. If, however, blood cells are observed flowing in a broad path through the blood vessel, they are more likely to contact the artery wall.

When the blood is able to contact the artery wall, so are the less desirable substances flowing with it. So, the lower the PBR score, the denser the flow channel, and the better the artery wall is protected. The higher the score, the broader the channel, and the more likely the artery wall will contact fats, cholesterol and oxidation.

PBR values vary based on health and conditions. For example, healthy young males would have a typical PBR ranging from 1.7 to 2 microns. Subjects with Type II Diabetes tend to have a PRB averaging 2.2 microns. PBRs of subjects in the Intensive Care Unit average 3 microns. Premenopausal women have PBR values that vary based on their menstrual cycles, with greater numbers at the beginning of the cycle (2.5 microns) and lower numbers toward the end of the cycle.

GycoCheck test results also show that conference attendees, which included health care providers, dieticians, endocrinologists, cardiologists and primary care physicians, had better GlycoCheck scores overall than their peers in the general U.S. population. The results also indicate a definite trend observed with regards to the PBR reduction as the result of supplementation with Arterosil HP, almost reaching statistical significance for the males.

Even after only one or two rounds of Arterosil HP and in less than 48 hours, PBR measurements were very close to statistically significant, and mimics well what Vascular Health Sciences continues to observe in controlled clinical trials.

For more information about Arterosil HP and how health practitioners can integrate it into their practices, visit ArterosilHP.com.

About Vascular Health Sciences
Founded in 2010, Vascular Health Sciences explores technologies, develops products and disseminates information to increase awareness and promote the proper care of the endothelial glycocalyx. Vascular Health Sciences is committed to increasing awareness of the glycocalyx and its role in vascular health, and to providing products supporting the care of this essential system. For more information, visit VascularHealthSciences.com, or follow Arterosil HP on Twitter.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebammgresults/arterosilhp/prweb10275975.htm